对于中枢神经系统药物的表型方法
Raahul Sharma1, Caitlin R M Oyagawa2, Hamid Abbasi3
1Centre for Brain Research, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland 1023, New Zealand; Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland 1023, New Zealand.
Trends in pharmacological sciences
|October 22, 2024
概括
开发用于中枢神经系统 (CNS) 的药物面临高失败率. 本研究回顾了使用患者细胞和先进查方法进行表型分析,以改善药物发现和针对脑疾病的标识.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 中枢神经系统 (CNS) 药物开发具有很高的临床失败率.
- 表型分析对于将药物发现转化为复杂脑疾病的临床治疗至关重要.
- 来自患者的大脑细胞提供了最准确的中枢神经系统疾病表型的回顾.
研究的目的:
- 批评将患者衍生细胞与中枢神经系统药物发现的更高通量模型集成的平台.
- 探索改善复合物库选和药物向解卷的策略.
- 对表型选的异常目标解卷方法进行审查.
主要方法:
- 患者衍生脑细胞与永生细胞模型的整合,以获得平衡的有效性和可扩展性.
- 传统的化学基因组化合物库和新型碎片库的选.
- 审查新兴的图书馆策划策略和不可知目标解卷方法,如化学蛋白质学和人工智能.
主要成果:
- 对当前平台的批评强调了需要提高药物查的命中率和质量.
- 新型碎片库和先进的策划策略显示出更容易处理的目标解构的前景.
- 不断发展的不可知性目标解卷方法有助于从表型查阐明药物机制.
结论:
- 将患者衍生细胞与可扩展模型相结合的平台正在推动中枢神经系统药物发现.
- 改进的图书馆选和目标解卷策略对于合理的命中药物优化至关重要.
- 包括人工智能在内的不可知性目标解卷是识别和优化新型中枢神经系统药物点的关键.
更多相关视频
相关概念视频
Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
CNS Stimulants: Psychedelic Agents
127
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
127
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Drug Delivery: Parenteral Route
434
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
434
Antipsychotic Drugs: Typical and Atypical Agents
159
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
159
Drugs Affecting Neurotransmitter Release or Uptake
961
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
961


